Basic Information | Post buying leads | Suppliers | Cas Database |
Name |
Adenosine triphosphate |
EINECS | 200-283-2 |
CAS No. | 56-65-5 | Density | 2.636 g/cm3 |
PSA | 308.56000 | LogP | -1.04780 |
Solubility | N/A | Melting Point |
187 - 190oC (Decomposes) |
Formula | C10H16N5O13P3 | Boiling Point | 951.429 °C at 760 mmHg |
Molecular Weight | 507.184 | Flash Point | 529.205 °C |
Transport Information | N/A | Appearance | white crystalline powder |
Safety | 22-24/25 | Risk Codes | N/A |
Molecular Structure | Hazard Symbols | N/A | |
Synonyms |
5'-ATP;ATP;ATP(nucleotide);Adenosine 5'-triphosphate;Adenosine 5'-triphosphoric acid;Adenosine triphosphate;Adenosine, 5'-(tetrahydrogen triphosphate);Adenylpyrophosphoric acid;Adephos;Adetol;Adynol;Atipi;Atriphos;Cardenosine;Fosfobion;Glucobasin;Myotriphos;Phosphobion;Striadyne;Triadenyl;Triphosphaden;Triphosphoric acid adenosine ester; |
Article Data | 124 |
Conditions | Yield |
---|---|
With dihydroxyacetone phosphate; ethylenediaminetetraacetic acid; DL-dithiothreitol; NAD; trisodium thiophosphate; 2-oxo-propionic acid; magnesium chloride; phosphoglycerate kinase; immobil. triosephosphate isomerase; glyceraldehyde-3-phosphate dehydrogenase; lactate dehydrogenase In water for 72h; Ambient temperature; 1) pH 7.5; | A 80% B n/a C n/a |
Conditions | Yield |
---|---|
With tetrakis(tetra-n-butylammonium) hydrogen triphosphate In acetonitrile for 48h; Ambient temperature; | 72% |
5'-adenosine monophosphate
A
adenosine 5'-diphosphate
B
ATP
C
adenosine 5'-tetraphosphate
Conditions | Yield |
---|---|
With manganese(ll) chloride; tri-1-benzimidazolylphosphine oxide at 50℃; for 72h; N-ethylmorpholine buffer (pH 7.0); | A 65% B 17% C 3% |
With magnesium chloride; tri-1-benzimidazolylphosphine oxide at 50℃; for 72h; N-ethylmorpholine buffer (pH 7.0); | A 26% B 36% C 18% |
adenosine 5'-<α-thio>triphosphate
ATP
Conditions | Yield |
---|---|
With dihydrogen peroxide | 65% |
Conditions | Yield |
---|---|
In acetonitrile for 23h; | 55% |
Conditions | Yield |
---|---|
With phosphorotriimidazolide; magnesium chloride at 22℃; for 168h; N-ethylmorpholine buffer (pH 7.0); | A 25% B 43% |
With 2,3,6-trimethyl-beta-cyclodextrin In water at 37℃; Product distribution; equilibrium constant phosphate buffer, pH 7.00; | |
With magnesium; β‐cyclodextrin In water at 37℃; Product distribution; equilibrium constant phosphate buffer, pH 7.00; |
ATP
Conditions | Yield |
---|---|
With bis(tri-n-butylammonium) pyrophosphate In N,N-dimethyl-formamide | 42% |
Conditions | Yield |
---|---|
With yeast-maceration juice |
Conditions | Yield |
---|---|
With creatine-kinase beim Behandeln mit einem Enzym-Praeparat aus Escherichia coli; |
Conditions | Yield |
---|---|
With Tri-n-octylamine; phosphoric acid; cyclopentanone-[O-(4-nitro-benzenesulfonyl)-oxime ]; N,N-dimethyl-formamide | |
With pyridine; phosphoric acid; water; dicyclohexyl-carbodiimide Reagens 4: Tributylamin; | |
With 5-phosphoribosyl 1-pyrophosphate synthetase; 5-phosphoribosyl 1-pyrophosphate Enzyme kinetics; |
Molecular Formula: C10H16N5O13P3
Molar mass: 507.181 g/mol
EINECS: 200-283-2
Density: 2.63 g/cm3
Flash Point: 529.2 °C
Index of Refraction: 1.904
Boiling Point: 951.4 °C at 760 mmHg
Vapour Pressure: 0 mmHg at 25°C
Storage temp: -20°C
Form: Lyophilized powder
Product categories of Adenosine triphosphate (56-65-5): Pharmaceutical Intermediate;Nucleic acid
Structure of Adenosine triphosphate (56-65-5):
XLogP3-AA: -5.7
H-Bond Donor: 7
H-Bond Acceptor: 17
Systematic Name: [5-(6-Aminopurin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate
SMILES: O=P(O)(O)OP(=O)(O)OP(=O)(O)OCC3OC(n2cnc1c(ncnc12)N)C(O)C3O
InChI: InChI=1/C10H16N5O13P3/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(26-10)1-25-30(21,22)28-31(23,24)27-29(18,19)20/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H,23,24)(H2,11,12,13)(H2,18,19,20)
InChIKey: ZKHQWZAMYRWXGA-UHFFFAOYAM
Std. InChI: InChI=1S/C10H16N5O13P3/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(26-10)1-25-30(21,22)28-31(23,24)27-29(18,19)20/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H,23,24)(H2,11,12,13)(H2,18,19,20)
Std. InChIKey: ZKHQWZAMYRWXGA-UHFFFAOYSA-N
Adenosine triphosphate (56-65-5) can be used for pharmaceutical intermediate.
1. | dni-hmn:lym 10 µmol/L | CNREA8 Cancer Research. 42 (1982),2092. | ||
2. | oms-hmn:oth 10 µmol/L | JIDEAE Journal of Investigative Dermatology. 65 (1975),52. | ||
3. | dni-mus:leu 2 µmol/L | CHTHBK Chemotherapy. 27 (1981),61. | ||
4. | ipr-rat LD50:200 mg/kg | BJANAD British Journal of Anesthesia. 53 (1981),305. | ||
5. | ipr-mus LD50:2780 mg/kg | PCJOAU Pharmaceutical Chemistry Journal (English Translation). Translation of KHFZAN. 20 (1986),160. |
EPA Genetic Toxicology Program. Reported in EPA TSCA Inventory.
Poison by intraperitoneal route. Human mutation data reported. When heated to decomposition it emits toxic fumes of POx and NOx.
Safety Statements:
22: Do not breathe dust
24: Avoid contact with skin
25: Avoid contact with eyes
Adenosine triphosphate (56-65-5) also can be called Atriphos ; Striadyne ; Glucobasin ; Triadenyl ; 9-[5-O-(Hydroxy{[hydroxy(phosphonooxy)phosphoryl]oxy}phosphoryl)pentofuranosyl]-9H-purin-6-amine .